Healthcare dealmakers eye M&A resurgence in second Trump term

Healthcare dealmakers gathering in San Francisco for the industry's premier annual conference this week say they expect a resurgence of deals exceeding $10 billion due to the potential for less antitrust scrutiny under President-elect Donald Trump